• 2017R&Ddayvideo
  • Daiichi Sankyo Listed on DJSI World Index as the first Japanese company from the pharmaceutical sector
  • Partnership to launch “Access Accelerated”
  • e-healthy recipe

Featured Stories

Who We Are

Who We Are

Daiichi Sankyo is a global pharmaceutical company with its corporate origin in Japan.
read more ...

Investor Relations

Investor Relations

The Daiichi Sankyo Corporate Governance Report has been updated.
read more ...

Featured News

2018.07.02
Products
Daiichi Sankyo Obtains Approval for Additional Indication and Dosage for DiagnogreenⓇ for Injection 25 mg in Japan PDF
2018.06.18
Corporate
Daiichi Sankyo Announces Disposal of Treasury Shares as Restricted Share-Based Remuneration PDF
2018.06.18
R&D
Phase 3 QuANTUM-R Study Demonstrates Daiichi Sankyo’s Quizartinib Significantly Prolongs Overall Survival as Single Agent Compared to Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations PDF
2018.06.15
Products
Daiichi Sankyo Launches FENTANYL CITRATE TAPE for 1day “DAIICHI SANKYO” in Japan for Long-Acting Cancer Pain Relief PDF
2018.06.06
Corporate
Daiichi Sankyo’s U.S. Products Liability Litigation Settlement Program Moves Forward; More than 97 Percent of Eligible Litigants and Claimants Opt In (Update on previously disclosed item) PDF
2018.06.05
R&D
Daiichi Sankyo Presents Phase 3 ENLIVEN Study of Pexidartinib, Demonstrating Statistically Significant Clinical Improvement Across Multiple Endpoints in Patients with Tenosynovial Giant Cell Tumor at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting PDF
2018.06.01
R&D
Daiichi Sankyo Presents Long-Term Phase 1 Results of Antibody Drug Conjugate DS-8201 in Patients with HER2-Expressing Breast, Gastric and Other Solid Cancers at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting PDF
2018.06.01
R&D
Daiichi Sankyo Presents Preliminary Phase 1 Data for Antibody Drug Conjugate U3-1402 in Patients with HER3-Expressing Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting PDF

Topics